A phenomenal transformation in the treatment and care of patients with hepatitis C virus (HCV) has been discovered with the more effective and tolerable medications available now, a recent study reveals the findings.
HCV is an infection caused by a virus which attacks the liver and leads to inflammation
The study analyses all HCV antiviral treatment regimens, a prescribed course for treatment of the same, of 1,07,079 people initiated from 1999 to 2015 at the US Veterans Affairs national healthcare system.
The results of the study demonstrated that the cure rates increased steadily from 19.2 to 36.0 percent during 1999 to 2010. The same has witnessed a remarkable increase to 90.5 percent in 2015.
“The introduction of effective direct antiviral agents together with the allocation of appropriate funds and resources allowed the VA healthcare system to treat and cure hepatitis C in unprecedented numbers,” said Dr. George Ioannou, senior author of study.
“In fact, out of approximately 57,500 patients cured of hepatitis C in the VA since 1999, approximately half were cured in a single year in 2015,” Ioannou elaborated.
“The question is whether we are delivering these medications to the patients who need them and what obstacles there are to treating and curing the majority of hepatitis C infected patients,” Ioannou summarised.
News Source: ANI
Image Source: Shutterstock
Read More Health News